Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review

  • ID: 4418441
  • SWOT Analysis
  • 35 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • CCP Technologies Ltd
  • Genetic Technologies Ltd
  • Medibio Ltd
  • TBG Diagnostics Ltd
  • MORE
Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Antisense Therapeutics Ltd (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense pharmaceuticals for various medical conditions that have large unmet medical needs. It focuses on the development of antisense drugs in the areas of cancer treatment, respiratory diseases, immunology disorders and rare diseases. Antisense Therapeutics’s development pipeline comprises of ATL1103 which blocks GHr production and lowers blood IGF-I levels and is a potential treatment for growth hormone disorders such as Acromegaly; ATL1102 (injection), which reduces brain lesions is being development for the treatment of multiple sclerosis and also pre-clinical development stage for the treatment of asthma as an inhalation; and ATL1101 which is being investigated for the potential treatment for prostate cancer. Antisense Therapeutics is headquartered in Toorak, Victoria, Australia.

Antisense Therapeutics Ltd Key Recent Developments

Jun 16, 2017: Antisense Therapeutics: Positive effects seen with ATL1102 on Multiple Sclerosis “Black Hole” brain lesions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CCP Technologies Ltd
  • Genetic Technologies Ltd
  • Medibio Ltd
  • TBG Diagnostics Ltd
  • MORE
Section 1 - About the Company
  • Antisense Therapeutics Ltd - Key Facts
  • Antisense Therapeutics Ltd - Key Employees
  • Antisense Therapeutics Ltd - Key Employee Biographies
  • Antisense Therapeutics Ltd - Major Products and Services
  • Antisense Therapeutics Ltd - History
  • Antisense Therapeutics Ltd - Company Statement
  • Antisense Therapeutics Ltd - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Antisense Therapeutics Ltd - Business Description
  • Antisense Therapeutics Ltd - Corporate Strategy
  • Antisense Therapeutics Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Antisense Therapeutics Ltd - Strengths
  • Antisense Therapeutics Ltd - Weaknesses
  • Antisense Therapeutics Ltd - Opportunities
  • Antisense Therapeutics Ltd - Threats
  • Antisense Therapeutics Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Antisense Therapeutics Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 16, 2017: Antisense Therapeutics: Positive effects seen with ATL1102 on Multiple Sclerosis “Black Hole” brain lesions
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Antisense Therapeutics Ltd, Key Facts
  • Antisense Therapeutics Ltd, Key Employees
  • Antisense Therapeutics Ltd, Key Employee Biographies
  • Antisense Therapeutics Ltd, Major Products and Services
  • Antisense Therapeutics Ltd, History
  • Antisense Therapeutics Ltd, Key Competitors
  • Antisense Therapeutics Ltd, Ratios based on current share price
  • Antisense Therapeutics Ltd, Annual Ratios
  • Antisense Therapeutics Ltd, Annual Ratios
  • Antisense Therapeutics Ltd, Annual Ratios
  • Antisense Therapeutics Ltd, Interim Ratios
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Antisense Therapeutics Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Antisense Therapeutics Ltd, Performance Chart (2013 - 2017)
  • Antisense Therapeutics Ltd, Ratio Charts
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Therapeutic Goods Administration
  • TBG Diagnostics Ltd
  • Medibio Ltd
  • Genetic Technologies Ltd
  • CCP Technologies Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll